Sumitomo Seika Chemicals Company, Limited. (TYO:4008)
1,305.00
+3.00 (0.23%)
May 26, 2026, 9:55 AM JST
TYO:4008 Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 18,217 | 16,863 | 21,662 | 23,553 | 29,248 |
Cash & Short-Term Investments | 18,217 | 16,863 | 21,662 | 23,553 | 29,248 |
Cash Growth | 8.03% | -22.15% | -8.03% | -19.47% | 14.00% |
Receivables | 32,344 | 31,008 | 31,676 | 28,004 | 26,549 |
Inventory | 25,190 | 25,818 | 28,288 | 28,339 | 21,875 |
Other Current Assets | 6,611 | 6,433 | 5,365 | 5,299 | 3,640 |
Total Current Assets | 82,362 | 80,122 | 86,991 | 85,195 | 81,312 |
Property, Plant & Equipment | 58,655 | 51,682 | 39,867 | 34,528 | 34,308 |
Long-Term Investments | 7,114 | 5,225 | 5,665 | 4,545 | 5,377 |
Other Intangible Assets | 4,200 | 4,124 | 3,531 | 2,228 | 200 |
Long-Term Deferred Tax Assets | 399 | 377 | 249 | 154 | 76 |
Other Long-Term Assets | 2 | 2 | 2 | 1 | 1 |
Total Assets | 152,732 | 141,532 | 136,305 | 126,651 | 121,274 |
Accounts Payable | 16,308 | 17,504 | 19,827 | 19,157 | 16,590 |
Accrued Expenses | 1,124 | 1,022 | 1,029 | 999 | 981 |
Short-Term Debt | 2,978 | 13,328 | 11,216 | 12,195 | 11,016 |
Current Portion of Long-Term Debt | - | - | - | - | 3,036 |
Current Portion of Leases | 209 | 171 | 178 | 157 | 144 |
Current Income Taxes Payable | 9,398 | 4,731 | 5,185 | 1,649 | 1,072 |
Other Current Liabilities | 2,790 | 3,764 | 2,084 | 4,197 | 4,686 |
Total Current Liabilities | 32,807 | 40,520 | 39,519 | 38,354 | 37,525 |
Long-Term Debt | 14,500 | 5,000 | - | - | - |
Long-Term Leases | 246 | 364 | 175 | 271 | 352 |
Pension & Post-Retirement Benefits | 728 | 661 | 482 | 1,050 | 1,379 |
Long-Term Deferred Tax Liabilities | 828 | 673 | 1,076 | 313 | 111 |
Other Long-Term Liabilities | 3 | 3 | 2 | 2 | 4 |
Total Liabilities | 49,112 | 47,221 | 41,254 | 39,990 | 39,371 |
Common Stock | 9,742 | 9,732 | 9,714 | 9,698 | 9,698 |
Additional Paid-In Capital | 7,596 | 7,587 | 7,569 | 7,552 | 7,539 |
Retained Earnings | 74,740 | 69,685 | 66,384 | 62,916 | 56,483 |
Treasury Stock | -4,203 | -3,203 | -2,208 | -1,208 | -1,207 |
Comprehensive Income & Other | 15,745 | 10,510 | 13,592 | 7,703 | 6,219 |
Total Common Equity | 103,620 | 94,311 | 95,051 | 86,661 | 78,732 |
Minority Interest | - | - | - | - | 3,171 |
Shareholders' Equity | 103,620 | 94,311 | 95,051 | 86,661 | 81,903 |
Total Liabilities & Equity | 152,732 | 141,532 | 136,305 | 126,651 | 121,274 |
Total Debt | 17,933 | 18,863 | 11,569 | 12,623 | 14,548 |
Net Cash (Debt) | 284 | -2,000 | 10,093 | 10,930 | 14,700 |
Net Cash Growth | - | - | -7.66% | -25.65% | 27.10% |
Net Cash Per Share | 21.73 | -30.24 | 150.26 | 162.02 | 213.97 |
Filing Date Shares Outstanding | - | 65.53 | 66.5 | 67.46 | 67.46 |
Total Common Shares Outstanding | - | 65.53 | 66.5 | 67.46 | 67.46 |
Working Capital | 49,555 | 39,602 | 47,472 | 46,841 | 43,787 |
Book Value Per Share | - | 1439.14 | 1429.35 | 1284.63 | 1167.09 |
Tangible Book Value | 99,420 | 90,187 | 91,520 | 84,433 | 78,532 |
Tangible Book Value Per Share | - | 1376.21 | 1376.25 | 1251.60 | 1164.12 |
Order Backlog | - | 3,519 | 1,791 | 3,959 | 1,030 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.